Pathogenic variants in high- and moderate-penetrance breast cancer susceptibility genes (BRCA1, BRCA2, TP53, CHEK2, RAD51C, and PALB2) account for about 27% of early-onset and familial breast cancers in Pakistan [13–17], leaving a substantial proportion of cases unexplained. This evidence concerns the gene BRCA2 and breast carcinoma.